At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
ESP with Bupivacaine 0.5% +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Erector Spinae Plane Block For Analgesia Following Video-Assisted Thoracoscopic Surgery : A Multi-Center Randomized Controlled Trial
In Brief
A clinical study evaluating ESP with Bupivacaine 0.5% and ESP with Saline 0.9% for Thoracic Surgery, Video-Assisted. Completed, enrolled 52 participants across 1 site.
Detailed Summary
Erector spinae (ESP) block is a recently described plane block designed to block the dorsal and ventral rami of the thoracic spinal nerves. It is meant to block the ipsilateral trunk. The aim of the study is to demonstrate the efficacy of the ESP block as postoperative analgesia for VATS surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThoracic Surgery, Video-Assisted
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartNov 2018
First PostedMar 2019
Primary CompletionDec 2021
TodayJul 2026
First PostedMar 4, 2019
Enrollment StartNov 29, 2018
Primary CompletionDec 16, 2021
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.3 years ago
Interventions
ESP with Bupivacaine 0.5%procedure
Regional anesthesia procedure with Bupivacaïne 0.5%
ESP with Saline 0.9%procedure
Regional anesthesia procedure with Normal Saline